Foscarbidopa is a prodrug of carbidopa and functions as a peripheral dopa-decarboxylase inhibitor used in fixed-dose combination therapies for the treatment of advanced Parkinson's disease. By acting as… Read more
Foscarbidopa is a prodrug of carbidopa and functions as a peripheral dopa-decarboxylase inhibitor used in fixed-dose combination therapies for the treatment of advanced Parkinson's disease. By acting as a phosphate ester derivative, it improves the solubility and delivery of therapeutic agents designed to reduce motor fluctuations in patients with inconsistent dopamine levels. This category provides access to essential analytical materials, including reference standards for the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for impurity profiling, rigorous method validation, and consistent quality control throughout drug development and manufacturing processes. These compounds ensure accuracy when characterizing degradation products and quantifying trace components, facilitating adherence to regulatory standards for safety and efficacy in Parkinson's disease treatments.